Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?

Octreotide is a somatostatin analogue used for treating congenital chylothorax and congenital hyperinsulinism in infants. By increasing splanchnic arteriolar resistance and decreasing gastrointestinal blood flow, octreotide indirectly reduces lymphatic flow in chylous effusions. Splanchnic ischaemia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Chandran, Suresh, Agarwal, Arpan, Llanora, Genevieve Villablanca, Chua, Mei Chien
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021135/
https://ncbi.nlm.nih.gov/pubmed/32051156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232062
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak